Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06206837

Active, not recruiting

A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

Breast Cancer
NCT02767661

Completed

Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer (MECCA)

Breast Cancer
NCT04996316

Enrolling by invitation

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Breast Carcinoma
NCT06009627

Completed

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

Breast Cancer
NCT03025035

Completed

Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer

Breast Cancer
NCT05036096

Active, not recruiting

Cone Beam Breast CT for Breast Cancer Screening

Breast Cancer
NCT01310530

Active, not recruiting

Partial Breast Proton Therapy for Early Stage Breast Cancer

Breast Cancer
NCT04623554

Active, not recruiting

Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer (Neo-train)

Breast Cancer
NCT03070236

Active, not recruiting

PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions

Breast Cancer
NCT03624543

Active, not recruiting

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

Breast Cancer
NCT02999477

Completed

A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer

Breast Cancer
NCT05138510

Completed

Sexual Health in Breast Cancer Patients

Breast Cancer
NCT06311383

Completed

A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line Treatment (RIBANNA)

Breast Cancer
NCT05731791

Active, not recruiting

Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation (PPI)

Breast Cancer
NCT04509648

Active, not recruiting

Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer (ARROW)

Breast Cancer
NCT06513364

Completed

Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer

Breast Cancer
NCT02086578

Completed

Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions

Breast Cancer
NCT04290793

Active, not recruiting

Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer

Breast Cancer
NCT03832920

Completed

Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure (ANIBPV)

Breast Cancer
NCT06081127

Completed

Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function (B-PREPed)

Breast Cancer
NCT06156397

Completed

The Effect of Technological Based Rehabilitation Practices After Breast Cancer Surgery

Breast Cancer
NCT02301767

Active, not recruiting

MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study

Breast Cancer
NCT03285412

Active, not recruiting

CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer (LEADER)

Breast Cancer
NCT05069038

Active, not recruiting

Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy

Breast Cancer
NCT03818087

Active, not recruiting

Elevate! : An Elderly Breast Cancer Cohort Study

Breast Cancer
NCT04394325

Completed

Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer

Breast Cancer
NCT05325151

Active, not recruiting

Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer

Breast Carcinoma
NCT03359759

Completed

Evaluation of Efficiency in Cancerology of New Technologies as Telemedicine and Conected Objects (e-DomSanté) (e-DomSanté)

Breast Cancer
NCT01358877

Completed

A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer (APHINITY)

Breast Cancer
NCT02263014

Active, not recruiting

Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)

Breast Cancer
NCT05757427

Completed

Pilot Clinical Evaluation of a Microwave Imaging System for Breast Cancer Detection

Breast Cancer
NCT04193059

Active, not recruiting

Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer (PANSY)

Breast Cancer
NCT03445637

Completed

Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®

Breast Neoplasm
NCT03284957

Terminated

Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer (AMEERA-1)

Breast Cancer
NCT06233383

Completed

Developing Screening Clinical Breast Examination Implementation Strategies in South Africa

Breast Cancer
NCT01153035

Active, not recruiting

Excision Followed by Radiofrequency Ablation for Breast Cancer (ABLATE)

Breast Cancer
NCT02603341

Active, not recruiting

Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial

Breast Cancer
NCT02510456

Completed

Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging (DOSI)

Breast Cancer
NCT00462696

Completed

MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer (ISNA-Sein)

Breast Cancer
NCT06465368

Completed

A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause

Breast Cancer
NCT05654532

Active, not recruiting

Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer

Breast Cancer
NCT03959891

Active, not recruiting

AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)

Breast Cancer
NCT03581136

Active, not recruiting

Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod

Breast Cancer
NCT05160545

Active, not recruiting

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer

Breast Cancer
NCT04280536

Active, not recruiting

Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

Breast Cancer
NCT03820063

Active, not recruiting

Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study (TRAIN-3)

Breast Cancer
NCT04191382

Terminated

Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer (AMEERA-4)

Breast Cancer
NCT01827969

Withdrawn

Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy (USF)

Breast Tumor
NCT05025020

Active, not recruiting

Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery

Breast Cancer
NCT03083288

Active, not recruiting

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations